Sperm Function Testing Market

The Sperm Function Testing Market is valued at USD 423.44 Mn in 2026 and is projected to reach USD 624.2 Mn, growing at a CAGR of 6% by 2033.

Cutting-edge Advent of Next-generation Semen Testing Augurs Well for Sperm Function Testing Market

Infertility affects 8–10% of couples globally, and in 50% of those cases, male infertility is the primary factor, according to The Lancet (2020). Growth in the testing sector and semen examination facilities will considerably drive the global sperm function testing market throughout the course of the projected period. The semen analysis may be the most important lab test for clinically evaluating infertility. The limits of semen assessment provide information on the testicular production of sperm, the capacity and patency of the male conceptive plot, and the movement of the ornamentation organs. Male infertility cases are on the rise owing to several interrelated problems, including obesity, which lowers the levels of testosterone needed to drive sperm production, diabetes brought on by obesity, smoking and alcohol usage, which impact sperm count and quality, and many others. It is thus recommended to test first because several manufacturers have incorporated cutting-edge features into their next-generation sperm function testing that address the issues of time-consuming diagnostic tasks, discomfort or pain experienced by androsurgeons after androsurgery, and the desired depth and view of the target tissue during surgery. This is expected to drive the growth of sperm function testing market.

Demand for infertility services is generally rising and one of the key factors behind this rise is the growing number of working women, and the postponement of marriage and childbirth. Identifying the disease and treating the male partner are essential steps that can help couples have better reproductive and mental health. A wide range of leading semen assessment strategies, such as PC helped semen examination (CASA) by indicative labs, and an increase in interest in front line wealth systems like IUI, and IVF are among the factors that are anticipated to support the growth of the overall semen examination market over the course of the forecast period. However, expensive testing costs may remain a major impediment facing sperm function testing market. About 10–15% of couples in the regeneration age group look for wealth evaluation at various locations across the world.

Sperm Function Testing Market: COVID-19 Impact

The COVID-19 flare-up has drastically altered many people's lives and organisations. People stopped visiting diagnostic centres as a result of the lockdown and widespread panic, which has decreased revenue of the sperm function testing market since it was impossible to determine how much money came from selling the instruments and frills. All diagnostic centres only saw covid testing, which had a detrimental effect on the growth of sperm function testing market. Because COVID-19 is becoming more prevalent throughout districts, a greater decline from the previous quarter is expected in the second. The COVID-19 pandemic has also adversely damaged economies and capital business sectors around the world, and it could result in a complete provincial or global financial slump. Such a financial disruption could have a negative impact on companies that produce sperm function tests, as the current pandemic has also had a significant financial impact on medical service providers, who have reduced their capital and overall spending. The overwhelming majority of medical clinics have also acknowledged their ongoing procurement of capital equipment.

Consistently Rising Frequency of Reproductive Concerns Fuel Sperm Function Testing Market Growth

Infertility was prevalent in 12.5% (CI 95% 11.7-13.3) of women and 10.1% (CI 95% 9.2-11.1) of men, according to Human Reproduction (Oxford, England). Higher socioeconomic position, later living with a partner, and having children later in life were all linked to increased occurrence. Infertility affects between 48 million couples and 186 million people worldwide, according to the World Health Organization. Infertility in men is typically brought on by problems with the ejection of semen, a lack of sperm or low sperm count, or irregular sperm form (morphology) and movement (motility). This will continue to keep the sperm function testing market buoyant.

Increased Awareness About Male Infertility Offers a Strong Impetus to Sperm Function Testing Market

According to Weill Cornell Medicine, a male component is a significant or contributing reason in at least half of all cases of infertility. This indicates that approximately 10% of American males who are trying to conceive, are infertile. Varicocele is the most frequently observed cause of infertility in men. This issue results in anomalies in the testis's ability to regulate its temperature because of swollen veins in the scrotum. In areas with high levels of environmental contamination, such as those with pesticides, herbicides, and water toxins, male infertility is more prevalent. In Victoria, Australia, the Department of Health reports that about 30% of reproductive problems are caused by men. Insemination using a concentrated sample of the man's semen and intracytoplasmic sperm injection are two treatments for poor sperm quality (ICSI). This is likely to sustain the scope of growth for sperm function testing market.

Uncertainty Around Haptic Criticism May Continue to Act as a Major Restraint for Sperm Function Testing Market

In any event, the ambiguity surrounding the haptic criticism of sperm testing serves as a barrier to the sperm function testing market growth. The lack of assets and high handling expenses are thought to place research facility Sperm Equipment on the higher end of the value scale. The high cost may particularly be a cause for concern in emerging business sectors, impeding the growth of the market for sperm function testing. However, the high evaluation of these new testing methods brings up a functionality issue that stalls market growth, particularly in these sectors.

Consumable and Disposable Remain Sought-after in Sperm Function Testing Market

Semen analyzers, centrifuges for sample preparation, semen test kits, disposables & consumables, and software are the different product categories. In 2021, the consumable & disposable category held the lion's share of the worldwide semen analysis market share, and it is predicted that this trend will hold during the forecast period. This is explained by their short lifespan as well as the increasing use of consumables and disposables in semen analysis tests. However, due to a rise in the use of semen test kits for home use due to its trustworthy quality and simple to understand results, the segment for semen test kits experienced the greatest CAGR over the projection period.

With Increasing Boom Around IVF Treatments, Fertility Centers Emerge Dominant in Sperm Function Testing Market

It is divided into fertility clinics, hospitals, diagnostic labs, and others, such as research institutes and home care settings, based on the end user. Due to rising population infertility rates, as well as rising IVF procedures and vasectomy procedures carried out at fertility clinics, the fertility centres held the biggest market share in 2021 and are anticipated to maintain their dominance in sperm function testing market throughout the projected period.

Highest Number of Infertility Cases, and Greater Awareness Seal the Top Spot for North America in Sperm Function Testing Market

The expansion of the North American market is largely attributed to the rise in the number of infertility sufferers. Education breakthroughs, later marriage and childbearing, rising obesity rates, and smaller family sizes are just a few of the factors that have contributed to this rising number. The market situation for sperm density testing is anticipated to continue to improve with the ongoing technological developments, the creation of sophisticated, user-friendly, more accurate, yet affordable testing devices, and rising male knowledge regarding fertility testing. In the anticipated time frame, it is thought to encourage the expansion of sperm function testing. According to a report from the Centers for Disease Control and Prevention (CDC), there are more than 440 clinics in the USA that offer services to those seeking treatment for infertility. According to the CDC's 2017 data, ART (Assisted Reproductive Technology) therapy accounts for close to 2% of live births in the United States and is growing by 5-10% year. During the predicted period, Europe is anticipated to have the greatest market for sperm density testing. The sperm function testing market will experience expansion during the anticipated period due to growing developments in the diagnosis and treatment of male infertility, the potential for genetic testing and microsurgery to discover and correct problems, and the presence of major market participants in the European region.

Sperm Function Testing Market: Competitive Landscape

Sandstone Diagnostics received approval from the U.S. FDA to distribute Trak Volume Cup, a device that enables at-home measurement of semen volume and hypospermia analysis. the Bonraybio Co. The LensHooke X1 PRO Semen Quality Analyzer doesn't provide a thorough evaluation of a man's wealth position. It is an in-vitro analytical methodology that has been suggested for human semen evaluation of individuals in professional medical settings to evaluate male fertility.

A few of the players in sperm function testing market include:

• Thermo Fisher Scientific
• Merck KGaA
• Danaher Corporation
• F. Hoffmann La Roche Ltd
• Beckman Coulter (Danaher)
• Siemens Healthineers
• Abbott Laboratories
• Fujifilm Holdings Corporation
• Nikon Instruments
• Olympus Corporation
• Hamilton Thorne Ltd.
• Microptic S.L.
• Medicult
• David Grannum Associates
• JAI A/S 

The Global Sperm Function Testing Market is Segmented as Below:

By Testing Type
• Computer-Assisted Semen Analysis (CASA)
• Differential Interference Contrast (DIC) Microscopy
• Fluorescence-Based Assays
• Sperm-mucus Interaction Tests
• Zona Binding Assays

By Sperm Function Parameters
• Concentration
• Motility
• Morphology
• Vitality
• DNA Fragmentation

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa